SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 38 filers reported holding SINOVAC BIOTECH LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $83,000 | -19.4% | 14,517 | -26.4% | 0.00% | -50.0% |
| Q4 2014 | $103,000 | +8.4% | 19,726 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $95,000 | -40.6% | 19,726 | -30.7% | 0.00% | -50.0% |
| Q2 2014 | $160,000 | -11.6% | 28,448 | +12.9% | 0.01% | -14.3% |
| Q1 2014 | $181,000 | – | 25,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |